NCT01182168
- Conditions
- Bladder Cancer, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +13 more
- Locations
-
- Memorial Sloan Kettering Cancer Center New York, United States
Clinical trial condition
Bladder Cancer
Explore clinical trials studying Bladder Cancer. Study availability and eligibility vary by location and protocol.
771 public trials
174 recruiting studies
Bladder Cancer trial results
NCT00506155
- Conditions
- Bladder Cancer, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +9 more
- Locations
-
- UT MD Anderson Cancer Center Houston, Texas, United States
NCT00365508
- Conditions
- Adenocarcinoma, Bladder Cancer, Bronchial Neoplasms, +80 more
- Locations
-
- Howard University Cancer Center Washington D.C., District of Columbia, United States
- CCOP - Mount Sinai Medical Center Miami Beach, Florida, United States
- Medical College of Georgia Cancer Center Augusta, Georgia, United States
- Fox Chase Virtua Health Cancer Program at Virtua Memorial Hospital Burlington County Mount Holly, New Jersey, United States
Completed
Cisplatin, Gemcitabine and Bevacizumab in Combination for Metastatic Transitional Cell Cancer
NCT00234494
- Conditions
- Bladder Cancer, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +9 more
- Locations
-
- University of Chicago Chicago, Illinois, United States
- Medical & Surgical Specialists, LLC Galesburg, Illinois, United States
- Oncology Hematology Associates of SW Indiana Evansville, Indiana, United States
- Fort Wayne Oncology & Hematology, Inc Fort Wayne, Indiana, United States
NCT00847015
- Conditions
- Bladder Cancer, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +10 more
- Locations
-
- Memorial Sloan-Kettering at Basking Ridge Basking Ridge, New Jersey, United States
- Memorial Sloan-Kettering Cancer Center @ Suffolk Commack, New York, United States
- Memorial Sloan-Kettering Cancer Center New York, United States
- Memorial Sloan-Kettering Cancer Center at Mercy Medical Center Rockville Centre, New York, United States
Completed
Phase II Trial of Stereotactic Radiosurgery Boost Following Surgical Resection for Brain Metastases
NCT00587964
- Conditions
- Bladder Cancer, Brain Diseases, Brain Metastasis, +73 more
- Locations
-
- Memorial Sloan-Kettering Cancer Center New York, United States
NCT02452944
- Conditions
- Bladder Cancer, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +9 more
- Locations
-
Not specified
NCT00397488
- Conditions
- Bladder Cancer, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +13 more
- Locations
-
- Memorial Sloan-Kettering Cancer Center New York, United States
NCT01459653
- Conditions
- Adnexal Diseases, Agranulocytosis, B-cell Lymphoma, +61 more
- Locations
-
- Sandoz Investigational Site Innsbruck, Austria
- Sandoz Investigational Site Kufstein, Austria
- Sandoz Investigational Site Leoben, Austria
- Sandoz Investigational Site Deurne, Belgium
NCT00234039
- Conditions
- Bladder Cancer, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +9 more
- Locations
-
- Arkansas Cancer Research Center at University of Arkansas for Medical Sciences Little Rock, Arkansas, United States
- USC/Norris Comprehensive Cancer Center and Hospital Los Angeles, California, United States
- Cancer Centers of Central Florida, PA Leesburg, Florida, United States
- Cancer Research Center of Hawaii Honolulu, Hawaii, United States